Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
2014
Diabetes and CVD risk during angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker treatment in hypertension: a study of 15 990 patients
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
30
References
12
Citations
NaN
KQI